Patient and Healthcare Professional Preferences for Characteristics of Long-Acting Injectable Antipsychotic Agents for the Treatment of Schizophrenia

por Robinson, Delbert G., Suett, Mark, Wilhelm, Amanda, Chaijale, Nayla, Franzenburg, Kelli R., Gandhi, Sanjay, Cloud, Blaine, Mychaskiw, Marko
Publicado 2023

Coding and Noncoding Gene Expression Biomarkers in Mood Disorders and Schizophrenia

por Mamdani, Firoza, Martin, Maureen V., Lencz, Todd, Rollins, Brandi, Robinson, Delbert G., Moon, Emily A., Malhotra, Anil K., Vawter, Marquis P.
Publicado 2013

Interaction of Cannabis Use Disorder and Striatal Connectivity in Antipsychotic Treatment Response

por Blair Thies, Melanie, DeRosse, Pamela, Sarpal, Deepak K, Argyelan, Miklos, Fales, Christina L, Gallego, Juan A, Robinson, Delbert G, Lencz, Todd, Homan, Philipp, Malhotra, Anil K
Publicado 2020

Greater Extracellular Free Water in First-Episode Psychosis Predicts Better Neurocognitive Functioning

por Lyall, Amanda E., Pasternak, Ofer, Robinson, Delbert G., Newell, Dominick, Trampush, Joey W., Gallego, Juan A., Fava, Maurizio, Malhotra, Anil K., Karlsgodt, Katherine H., Kubicki, Marek, Szeszko, Philip R.
Publicado 2017

mHealth for Schizophrenia: Patient Engagement With a Mobile Phone Intervention Following Hospital Discharge

por Ben-Zeev, Dror, Scherer, Emily A, Gottlieb, Jennifer D, Rotondi, Armando J, Brunette, Mary F, Achtyes, Eric D, Mueser, Kim T, Gingerich, Susan, Brenner, Christopher J, Begale, Mark, Mohr, David C, Schooler, Nina, Marcy, Patricia, Robinson, Delbert G, Kane, John M
Publicado 2016